These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2408970)

  • 21. Mucosal glucosamine synthetase activity in inflammatory bowel disease.
    Winslet MC; Poxon V; Allan A; Keighley MR
    Dig Dis Sci; 1994 Mar; 39(3):540-4. PubMed ID: 8131690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activities of 2'-5'oligoadenylate synthetase in peripheral blood mononuclear cells of patients with viral hepatitis, and chronic type B hepatitis during interferon therapy.
    Sugawara T; Matsushima T; Miyazaki T; Toyota J; Fujii N; Minagawa T
    Jpn J Med; 1986 May; 25(2):144-8. PubMed ID: 3747259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum interferon level and (2'-5')oligoadenylate synthetase activity in lymphocytes during clinical interferon application.
    Lodemann E; Nitsche EM; Lang MH; Gerein V; Altmeyer P; Holzmann H; Kornhuber B
    J Interferon Res; 1985; 5(4):621-8. PubMed ID: 2418131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating human leucocyte elastase in patients with inflammatory bowel disease.
    Adeyemi EO; Neumann S; Chadwick VS; Hodgson HJ; Pepys MB
    Gut; 1985 Dec; 26(12):1306-11. PubMed ID: 3853525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 2'-5' oligo-A-synthetase activity in bovine peripheral blood leukocytes and alveolar macrophages exposed to recombinant interferons and tumor necrosis factor-alpha.
    Ohmann HB; Campos M; Griebel PJ; Babiuk LA
    Can J Vet Res; 1989 Apr; 53(2):161-6. PubMed ID: 2713781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical value of the determination of an interferon-induced enzyme activity: studies of the 2'5' oligoadenylate synthetase activity in peripheral blood lymphocytes of patients.
    Chousterman S; Chousterman M; Reinert P; Thang MN
    Biomed Pharmacother; 1983; 37(4):176-80. PubMed ID: 6198003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Demonstration of 2-5A synthetase in human circulating mononuclear cells after oral administration of an interferon inducer isolated from a fraction of Escherichia coli and Klebsiella pneumoniae].
    Merlin G; Vanderhoven C; Page YM; Falcoff E
    C R Acad Sci III; 1985; 300(17):619-22. PubMed ID: 3939289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Indices of granulocyte activity in ulcerative colitis and Crohn's disease.
    Koldkjaer O; Klitgaard NA; Schmidt KG
    Dan Med Bull; 1977 Apr; 24(2):72-6. PubMed ID: 852316
    [No Abstract]   [Full Text] [Related]  

  • 29. Serum lysozyme in inflammatory bowel disease.
    Dobbins JW; Binder HJ; Spiro HM; Finch SC
    Gastroenterology; 1976 Mar; 70(3):469-71. PubMed ID: 1248707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thiol methyltransferase activity in inflammatory bowel disease.
    Roediger WE; Babidge WJ
    Gut; 2000 Aug; 47(2):206-10. PubMed ID: 10896911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum lysozyme in Crohn's disease and ulcerative colitis.
    Falchuk KR; Perrotto JL; Isselbacher KJ
    N Engl J Med; 1975 Feb; 292(8):395-7. PubMed ID: 1110725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo sensitivity and resistance of chronic myelogenous leukemia cells to alpha-interferon: correlation with receptor binding and induction of 2',5'-oligoadenylate synthetase.
    Rosenblum MG; Maxwell BL; Talpaz M; Kelleher PJ; McCredie KB; Gutterman JU
    Cancer Res; 1986 Sep; 46(9):4848-52. PubMed ID: 2942242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum lysozyme in Crohn's disease and ulcerative colitis.
    Helman CA; Novis BH; Bank S; Wormold L; Jacobs P
    S Afr Med J; 1977 Dec; 52(26):1042-4. PubMed ID: 609977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased levels of interferon-induced (2'--5') oligo-isoadenylate synthetase in mature T-lymphocytes and in differentiated Friend-erythroleukemic cells.
    Kimchi A
    J Interferon Res; 1981; 1(4):559-69. PubMed ID: 6180088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Raised serum activity of phospholipase A2 immunochemically related to group II enzyme in inflammatory bowel disease: its correlation with disease activity of Crohn's disease and ulcerative colitis.
    Minami T; Tojo H; Shinomura Y; Tarui S; Okamoto M
    Gut; 1992 Jul; 33(7):914-21. PubMed ID: 1644331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interferon-induced 2'-5' adenylate synthetase in vivo and interferon production in vitro by lymphocytes from systemic lupus erythematosus patients with and without circulating interferon.
    Preble OT; Rothko K; Klippel JH; Friedman RM; Johnston MI
    J Exp Med; 1983 Jun; 157(6):2140-6. PubMed ID: 6189954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Serum interferon level and (2'-5')-oligo(A) synthetase activity in malignant melanoma].
    Lodemann E; Lang MH; Oelmann R; Holzmann H
    Z Hautkr; 1990 Apr; 65(4):404-6. PubMed ID: 1695048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. (2'-5') Oligo A synthetase in human polymorphonuclear cells increased activity in interferon treatment and in viral infections.
    Schattner A; Merlin G; Bregman V; Hahn T; Levin S; Revel M; Wallach D
    Clin Exp Immunol; 1984 Aug; 57(2):265-70. PubMed ID: 6467673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical value of measuring the interferon-induced enzyme 2'-5'-oligoadenylate synthetase in children.
    Huppertz HI; Becker K; Kreth HW
    Acta Paediatr; 1992 Apr; 81(4):329-34. PubMed ID: 1376630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytokine production in patients with inflammatory bowel disease.
    Nakamura M; Saito H; Kasanuki J; Tamura Y; Yoshida S
    Gut; 1992 Jul; 33(7):933-7. PubMed ID: 1644332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.